Direktorat Registrasi ObatValid

TEOXIB

Claim this product
BPOM Number
DKI1916201644A1
Approved
21 November 2024
Expiry
9 October 2024
Form
SERBUK INJEKSI LIOFILISASI; 3.5 mg

About This Registration

TEOXIB is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1916201644A1. Its current registration status is Valid, with the licence valid until 9 October 2024. The product is registered to NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA. BPOM first approved this registration in October 2019. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 VIAL @ 3.5 MG SERBUK INJEKSI LIOFILISASI
Department
Direktorat Registrasi Obat
Data Last Updated
13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

BORTEZOMIB

Market Intelligence

Owner Portfolio
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA holds 567 BPOM registrations
Manufacturer Scale
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA produces 567 registered products
Registration Age
Registered for 6 years, 11 months
Expiry Status
Expired 718 days ago

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1